OpenURL Connection Search

Select item for more details and to access through your institution.

Prevalence of JCV, EBV, HPV, CMV and HSV Viruses in Iranian Patients with Gastrointestinal Cancers: A preliminary study.
Published in:
Iranian Journal of Gastroenterology & Hepatology (GOVARESH), 2021, v. 26, p. 10
By:
- Jamehdar, Saeid Amel;
- Goshayeshi, Ladan;
- Milani, Nasrin;
- khorasani, Elham Zaeif;
- Maghool, Fatemeh;
- Bary, Alireza;
- Goshayeshi, Lena
Publication type:
Article
Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial.
Published in:
2020
By:
- Allahyari, Abolghasem;
- Rahimi, Hossein;
- Khadem-Rezaiyan, Majid;
- Mozaheb, Zahra;
- Seddigh-Shamsi, Mohsen;
- Bary, Alireza;
- Kamandi, Mostafa;
- Azimi, Sajad Ataei;
- HasanAbadi, Saeed Eslami;
- Noferesti, Alireza;
- Shariatmaghani, Somayeh Sadat;
- Rafatpanah, Houshang;
- Khatami, Shohreh;
- Imani, Afshin Jabbar;
- Mortazi, Hassan;
- Nodeh, Mohammad Moeini
Publication type:
clinical trial
Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
Published in:
BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-09895-5
By:
- Allahyari, Abolghasem;
- Ehsanpour, Ali;
- Najafi, Behrouz;
- Ansarinejad, Nafiseh;
- Mehrzad, Valiollah;
- Kalantari, Behjat;
- Raafat, Jahangir;
- Ghadiany, Mojtaba;
- Shahi, Farhad;
- Gharib, Behrooz;
- Moazed, Vahid;
- Khosravi, Adnan;
- Mirpour, Mir Hossein;
- Salari, Sina;
- Mortazavizadeh, Seyedmohammadreza;
- Nekoyi, Amirabbas;
- Khani, Mohsen;
- Sadeghi, Alireza;
- Gharib, Sirus;
- Bary, Alireza
Publication type:
Article
Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
Published in:
2022
By:
- Allahyari, Abolghasem;
- Ehsanpour, Ali;
- Najafi, Behrouz;
- Ansarinejad, Nafseh;
- Mehrzad, Valiollah;
- Kalantari, Behjat;
- Raafat, Jahangir;
- Ghadiany, Mojtaba;
- Shahi, Farhad;
- Gharib, Behrooz;
- Moazed, Vahid;
- Khosravi, Adnan;
- Mirpour, Mir Hossein;
- Salari, Sina;
- Mortazavizadeh, Seyedmohammadreza;
- Nekoyi, Amirabbas;
- Khani, Mohsen;
- Sadeghi, Alireza;
- Gharib, Sirus;
- Bary, Alireza
Publication type:
Correction Notice
Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.
Published in:
2022
By:
- Allahyari, Abolghasem;
- Ehsanpour, Ali;
- Ansarinejad, Nafiseh;
- Mehrzad, Valiollah;
- Kalantari, Behjat;
- Raafat, Jahangir;
- Ghadiany, Mojtaba;
- Shahi, Farhad;
- Gharib, Behrooz;
- Moazed, Vahid;
- Khosravi, Adnan;
- Mirpour, Mir Hossein;
- Salari, Sina;
- Mortazavizadeh, Seyedmohammadreza;
- Nekoyi, Amirabbas;
- Khani, Mohsen;
- Sadeghi, Alireza;
- Gharib, Sirus;
- Bary, Alireza;
- Mirzania, Mehrzad
Publication type:
journal article

Found: 5

Prevalence of JCV, EBV, HPV, CMV and HSV Viruses in Iranian Patients with Gastrointestinal Cancers: A preliminary study.

Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial.

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.

Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial.